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We present the case of a woman, 47 years old, with type 1
diabetes mellitus. She was regularly treated with detemir
insulin (LevemirTM) tid, lispro protamine (Insulin Huma-
log Mix 25TM) according with glucose during the day.
She noticed the appearance of non-confluent urticariform
lesions on the thorax and upper limbs, totalling 20, with a
pruriginous papule at the site of subcutaneous insulin
Levemir injection after 4-6 hours. The lesions sponta-
neously regressed after 24 hours of the administration-
biphasic reaction. No other systemic manifestations or
triggers were verified. She had partial improvement with a
non-sedating H1 antihistamine. Laboratory evaluation was
negative for other autoimmune diseases. Total IgE <0.1
UI/mL, serologies for Cytomegalovirus, Epstein-Barr virus,
coxsackievirus, echovirus, HIV 1/2, hepatitis B/C virus
were also negative. High serum glycated hemoglobin A1c
levels (7.8%) were found and apparently correlated with
the cutaneous reaction. Skin tests were carried out with
Levemir insulin (100U/ ml, 3,5 mg/ml): negative prick test,
intradermal skin test 1/100, 1/10 and pure, showed a
papule equal to the initial one but with an extensive sur-
rounding erythema. Humalog insulin (100U/ml, 3,5mg/
ml): negative prick test, intradermal skin test 1/100, 1/10
and pure, with a papule equal to the initial one without
surrounding erythema. Pure protamine sulfate 10mg/ml
with negative results. Specific IgE: IgE human insulin<0.10
KU/L, bovine insulin IgE<0.10KU/L, porcine insulin
IgE<0.10 KU/L, human insulin specific IgG <2. Given the
results, it was decided to perform skin tests with an alter-
native Insulin:Lantus Insulin-glargina (100UI/ml-3,64mg)
with negative results. Insulin Levemir was suspended and
the patient began therapy with Lantus insulin, with no
reactions. Glycemic control was achieved after three
months.The patient stopped H1 antihistamine with no
recurrence of urticaria. Allergy to insulin analogues is rare
and requires early diagnosis, leading to a major therapeutic
challenge. Despite the of suspicion of insulin hypersensi-
tivity, it should be mantained until alergic investigation is
complete and a safe alternative can be found (if not, insu-
lin desensitization can be a therapeutic option).
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